RT Journal Article
SR Electronic
T1 Smoking, DNA methylation and lung function: a Mendelian randomization analysis to investigate causal relationships
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19003335
DO 10.1101/19003335
A1 Emily Jamieson
A1 Roxanna Korologou-Linden
A1 Robyn E. Wootton
A1 Anna L. Guyatt
A1 Thomas Battram
A1 Kimberley Burrows
A1 Tom R. Gaunt
A1 Martin Tobin
A1 Marcus Munafò
A1 George Davey Smith
A1 Kate Tilling
A1 Caroline Relton
A1 Tom G. Richardson
A1 Rebecca C. Richmond
YR 2019
UL http://medrxiv.org/content/early/2019/08/02/19003335.abstract
AB Whether smoking-associated DNA methylation has a causal effect on lung function has not been thoroughly evaluated. We investigated the causal effects of 474 smoking-associated CpGs on forced expiratory volume in one second (FEV1) in two-sample Mendelian randomization (MR) using methylation quantitative trait loci and genome-wide association data for FEV1. We found evidence of a possible causal effect for DNA methylation on FEV1 at 18 CpGs (p<1.2×10−4). Replication analysis supported a causal effect at three CpGs (cg21201401 (ZGPAT), cg19758448 (PGAP3) and cg12616487 (AHNAK) (p<0.0028). DNA methylation did not clearly mediate the effect of smoking on FEV1, although DNA methylation at some sites may influence lung function via effects on smoking. Using multiple-trait colocalization, we found evidence of shared causal variants between lung function, gene expression and DNA methylation. Findings highlight potential therapeutic targets for improving lung function and possibly smoking cessation, although large, tissue-specific datasets are required to confirm these results.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Integrative Epidemiology Unit which receives funding from the UK Medical Research Council and the University of Bristol (MC_UU_00011/1 and MC_UU_00011/5). This work was also supported by CRUK (grant number C18281/A19169) and the ESRC (grant number ES/N000498/1). T.G.R. is a UKRI Innovation Research Fellow (MR/S003886/1). R.C.R. is a de Pass Vice Chancellor Research Fellow at the University of Bristol.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicablePlease address correspondence and material requests to R.C.R.